TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
RARE

Ultragenyx

Healthcare · Biotechnology

14.90$ +3.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Ultragenyx (RARE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,264 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RARE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
515 541 546 498 435 491 817 806 765 720 1,008 959 880 1,135 1,233 1,314 1,268 1,760 1,598 1,512 1,485 1,522 1,384 1,321 1,618 1,545 1,383 1,311 1,238 1,491 1,307 1,618 1,538 1,503 1,312 1,306 1,190 1,532 1,296 1,264
473 498 445 420 391 244 582 547 567 522 787 699 613 851 894 906 872 1,295 1,071 949 847 857 708 679 1,013 884 766 702 599 732 596 965 800 817 699 720 643 951 657 606
142 161 160 91 60 100 227 111 83 113 270 131 123 434 298 336 197 714 384 291 198 308 154 160 392 133 86 102 73 214 112 481 151 174 127 166 212 434 175 125
473 498 425 400 371 244 571 547 503 460 715 618 527 755 663 813 766 1,202 965 846 737 740 598 543 889 748 629 552 442 577 412 764 622 610 494 477 435 693 413 292
– – – – – 5.2 3.7 17 9.2 13 16 21 23 33 155 23 28 23 25 25 25 44 28 37 31 40 43 71 79 73 100 106 93 122 99 124 115 159 121 200
0.0 0.0 0.0 0.0 0.0 0.8 2.1 3.3 5.6 7.1 11 14 14 12 11 11 14 13 12 15 15 16 18 21 22 27 27 28 32 34 36 40 43 45 46 46 52 52 55 59
18 17 17 16 16 22 21 21 20 20 45 59 64 75 83 85 49 74 88 143 119 141 177 207 235 260 278 – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44
0.0 0.0 0.0 0.0 0.0 142 137 133 130 129 129 129 129 129 129 131 131 131 131 131 131 131 160 159 158 160 159 158 157 166 165 166 165 178 177 175 173 176 174 172
59 67 57 68 69 107 94 102 103 111 121 139 153 482 624 618 602 605 543 540 551 600 588 643 1,150 1,193 1,163 1,182 1,206 1,216 1,167 1,186 1,185 1,241 1,161 1,148 1,174 1,605 1,525 1,548
50 60 52 63 64 71 58 66 67 75 67 75 90 103 197 220 201 190 127 127 136 181 167 221 227 261 218 244 254 280 246 273 285 344 292 293 340 384 325 351
– – – – – – – – – – 5.3 7.0 7.3 7.2 7.5 7.3 7.8 9.0 9.4 10 11 11 11 12 12 12 11 11 12 13 13 12 10 10 10 12 78 81 72 76
6.6 5.4 8.3 12 9.3 8.9 7.6 10 8.2 12 13 8.7 13 13 14 9.0 11 13 16 22 16 17 24 34 24 43 59 42 33 42 41 60 36 39 47 34 41 31 42 39
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 23 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
456 474 488 429 366 383 724 704 663 609 887 820 727 654 609 696 666 1,154 1,055 972 934 923 796 678 469 352 220 129 32 275 140 432 347 255 144 151 9.2 -80 -236 -291
-459 -531 -599 -672 -751 -833 -802 -855 -942 -1,030 -1,127 -1,226 -1,339 -1,433 -1,552 -1,527 -1,596 -1,620 -1,756 -1,878 -1,951 -2,074 -2,226 -2,384 -2,629 -2,781 -2,945 -3,105 -3,264 -3,388 -3,558 -3,690 -3,823 -3,957 -4,108 -4,223 -4,403 -4,532 -4,717 -4,809
40 41 42 42 42 43 49 50 50 51 53 58 58 58 58 61 61 65 67 68 68 69 70 70 70 70 70 71 72 81 84 87 95 96 96 98 100 100 101 102

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?